Form 4: Organon & Co. Insider Trades Common Stock

Lynette Holzbaur, SVP and Corporate Controller at Organon & Co., reported a transaction involving the acquisition of common stock.

Summary

• Lynette Holzbaur, SVP and Corporate Controller of Organon & Co., acquired 26,448.366 shares of common stock on May 6, 2026.
• The acquisition was made at a price of $13.3498 per share.
• Following this transaction, Holzbaur beneficially owns 52,850.793 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as insider purchases can indicate confidence, but it is a routine disclosure without broader financial performance data.

Positives

• Insider acquisition of company stock can signal confidence in the company's future prospects.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of common stock by a corporate officer, are closely watched by investors as potential indicators of management's view on the company's valuation and future performance within the pharmaceutical and healthcare sector.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive signal of management's confidence in the company's stock value.

Key Dates

Keywords

Organon & Co., OGN, Insider Trading, Form 4, Common Stock, Securities Transaction, Lynette Holzbaur